5Parker LC,Whyte MKB,Dower SK,et al.The expression and roles of Toll-like receptors in the biology of the human neutrophil[J].J Leuk Biol,2005,77:886-892.
6Sabroe I,Dower SK,Whyte MKB.The role of Toll-kike receptors in the regulation of neutrophil migration,activition,and apoptosis[J].Clin Infect Dis,2005,41:S421-S426.
7Reaves TA,Chin AC,Parkos CA,et al.Neutrophil transepithelial migration:role of toll-like receptors in mucosal inflammation[J].Mem Inst Oswaldo Cruz,2005,100(Suppl 1):191-198.
8Kurt-Jones EA,Mandell L,Whitney C,et al.Role of Toll-like receptor 2(TLR2) in neutrophil activation:GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils[J].Blood,2002,100:1860-1868.
10Liu Y,Shaw SK,Ma S,et al.Regulation of leukocyte transmigration:cell surface interactions and signaling events[J].J Immunol,2004,172(1):7-13.
二级参考文献39
1Hemmi H, Kaisho T, Takeda K, et al. The roles of Toll-like receptor 9, MyD88 and DNA-dependent protein kinase catalytic subunit in the distinct CpG DNA on dendritic cell subsets[J]. J Immunol, 2003,170(6):3059-3064.
2Krug A, Rothenfusser S, Selinger S, et al. CpG-A oligonucleotides induce a monocyte-deprived dendritic cell-like phenotype that preferentially activates CD8 T cells[J]. J Immunol, 2003,170(7):3468-3477.
3Weiwen J, Reich CF, You D, et al. Induction of immune activation by a novel immunomodulatory oligonucleotide without thymocyte apoptosis[J]. Biochem Biophys Res Commun, 2004,318(1):60-66.
4Kerkmann M, Rothenfusser S , Hornung V, et al. Activation with CpG-A and CpG-B oligonucletides reveals two distinct regulatory pathways of type Ⅰ IFN synthesis in human plasmacytoid dendritic cells[J]. J Immunol, 2003,170(9):4465-4474.
5Rothenfusser S, Tuma E, Endres S, et al. Plasmacytoid dendritic cells: the key to CpG[J]. Human Immunol, 2002, 63(12):1111-1119.
6Agrawal A, Lingappa J, Leppla SH, et al. Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin[J]. Nature,2003,424(6946):329-334.
7Arpinati M, Chirumbolo G, Urbini B, et al. Role of plasmacytoid dendritic cells in immunity and tolerance after allogeneic hematopoietic stem cell transplantation[J]. Transplant Immunol,2003,11(3-4):345-356.
8Briere F, Bendriss-Vermare N, Delale T, et al. Origin and filiation of human plasmacytoid dendritic cells[J]. Human Immunol,2002,63(12):1081-1093.
9Larsson M, Beignon AS, Bhardwaj N. DC-virus interplay: a double edged sword[J ]. Semin Immunol, 2004,16(3),147-161.
10Vollmer J, Weeratna R, Payette P, et al. Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities[J]. Eur J Immunol, 2004,34(1):251-262.
6Pugliese A, Vidotto V, Beltramo T, et al. Phagocytic activity in human immunodeficiency virus type 1 infection[J]. Clin Diagn Lab Immunol, 2005,12 : 889-895.
7Sistig S, Lukac J, Vucicevic-Boras V, et al. Salivary immunoglobulin A and G subclasses in HIV positive patients [J].Eur J MedRes, 2003,8:543-548.
8Cutlerl CW, Jotwani R. Dendritic cells at the oral mucosal interface[J]. J Dent Res, 2006,85:678-689.
9Liu X, Zha J, Chen H, etal. Human immunodeficiency virus type 1 infection and replication in normal human oral keratinocytes[J].J Virol, 2003, 77:3470-3476.
10Morrow G, Vachot L, Vagenas P, et al. Current concepts of HIV transmission[J]. Curr Infect Dis Rep, 2008,10:133- 139.
